Cargando…
Synergism Between Circulating Tumor Necrosis Factor Receptor 2 and HbA(1c) in Determining Renal Decline During 5–18 Years of Follow-up in Patients With Type 1 Diabetes and Proteinuria
OBJECTIVE: We studied the serum concentration of tumor necrosis factor receptor 2 (TNFR2) and the rate of renal decline, a measure of the intensity of the disease process leading to end-stage renal disease (ESRD). RESEARCH DESIGN AND METHODS: A cohort of 349 type 1 diabetic patients with proteinuria...
Autores principales: | Skupien, Jan, Warram, James H., Niewczas, Monika A., Gohda, Tomohito, Malecki, Maciej, Mychaleckyj, Josyf C., Galecki, Andrzej T., Krolewski, Andrzej S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140154/ https://www.ncbi.nlm.nih.gov/pubmed/24898299 http://dx.doi.org/10.2337/dc13-1983 |
Ejemplares similares
-
Early Progressive Renal Decline Precedes the Onset of Microalbuminuria and Its Progression to Macroalbuminuria
por: Krolewski, Andrzej S., et al.
Publicado: (2014) -
Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy
por: Skupien, Jan, et al.
Publicado: (2019) -
Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease
por: Niewczas, Monika A., et al.
Publicado: (2017) -
Hepatic insulin clearance is increased in patients with high HbA1c type 2 diabetes: a preliminary report
por: Okura, Tsuyoshi, et al.
Publicado: (2020) -
The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease
por: Skupien, Jan, et al.
Publicado: (2012)